- Hologic (NASDAQ:HOLX) said its V5 global endometrial ablation designed to treat a wide range of cervical and uterine anatomies had been approved in Canada and Europe.
- NovaSure V5 has a cervical seal, featuring EndoForm technology, designed to increase the sealing surface and accommodate a range of cervical canals and anatomical variability.
- The NovaSure device enables an endometrial ablation procedure for the treatment of abnormal uterine bleeding.
- Press Release
Recommended For You
More Trending News
See More »